My Top Biotech Stock Just Crushed Earnings

The Nvidia Killer is Here

Sponsored

Artificial intelligence could have already made you a millionaire… Because back in 2013, researchers from Stanford University built the “world's largest virtual brain” with Nvidia chips. This single event marked the beginning of the chipmaker's reign as the “King of AI.” You could've raked in 12,035% gains had you bought Nvidia shares when this story became public. That's enough to turn a $9,000 stake into more than $1 million. But there's no reason to beat yourself up for missing out on this life-changing opportunity. Today you have a second shot at six- or even seven-figure gains. Because there's a new player in town… One that's set to dethrone Nvidia. This off-the-radar company from California is about to release an AI chip that's superior to Nvidia's technology. I'm talking about a 100x performance boost. Access to this kind of chip is still highly restricted. The U.S. Air Force is one elite client that was allowed to use it early. But soon it will be available to the mainstream. And if you position yourself BEFORE this chip reaches the mass market, you could turn every $1 into $120… Just like early Nvidia investors did. I just published a brand-new presentation on this unique opportunity. Access is instant and free. Get the full story here while there's still time.


Medtronic (MDT), a titan in the biotech realm, has not just been making waves but causing tsunamis with its stellar financial performances and groundbreaking strategic leaps forward.

And it just crushed its most recent earnings report.

As we pull back the curtain on this industry behemoth, we uncover a tapestry of innovation, resilience, and ambition.

Dive with us into this report, where we unravel all the reasons that make Medtronic not just an attractive investment but a thrilling voyage into the future of biotech.

Key Financial Highlights

Revenue Growth: Medtronic reported a Q1 worldwide revenue of $7.702 billion, marking a 4.5% increase as reported and a 6.0% organic growth. This growth reflects the company's strength across various businesses and geographies, underpinned by innovation and robust underlying fundamentals.

Earnings Per Share (EPS): While the GAAP diluted EPS of $0.59 saw a 16% decrease, the non-GAAP diluted EPS of $1.20 increased by 6%. This growth, despite the unfavorable impact from foreign currency translation, indicates the company's ability to maintain profitability.

Guidance for FY24: Medtronic has raised its FY24 organic revenue growth guidance to 4.5% and increased its non-GAAP EPS guidance range to $5.08 to $5.16, reflecting confidence in its future performance.

Operational Highlights

Product Launches: Medtronic has commenced U.S. launches of the MiniMed™ 780G system with Guardian™ 4 sensor in the Diabetes segment and the Micra™ AV2 and Micra™ VR2 leadless pacemakers in the Cardiovascular segment. These launches signify the company's commitment to innovation and addressing patient needs.

Cardiovascular Portfolio: This segment saw a revenue of $2.850 billion, a 5.5% increase as reported, driven by growth in Defibrillation Solutions, Cardiovascular Diagnostics, and Cardiac Pacing Therapies.

Neuroscience Portfolio: With a revenue of $2.219 billion, this segment witnessed growth in Spine & Biologics, ENT, and Brain Modulation, highlighting the company's diversified strength.

Medical Surgical Portfolio: Reporting a revenue of $2.039 billion, this segment saw growth in Advanced Surgical Technologies and Patient Monitoring, emphasizing the company's broad-based capabilities.

Diabetes: The Diabetes segment reported a revenue of $578 million, a 6.8% increase, driven by the MiniMed™ 780G system's adoption and the strength of the Guardian™ 4 sensor.

Management's Perspective: Geoff Martha, Medtronic's chairman and CEO, expressed satisfaction with the company's strong start to the fiscal year, emphasizing the broad-based results across all segments. The company's focus on transformation aims to ensure sustainable growth and maximize shareholder value.

Conclusion

Medtronic's recent financial results, combined with its strategic advancements and management's optimistic outlook, make it a promising biotech stock for potential investors. The company's commitment to innovation, its diversified portfolio, and its ability to navigate challenges position it well for future growth. Investors seeking a robust biotech stock with a proven track record and a bright future should consider Medtronic plc as a top contender.


NASA and Bill Gates are ALL IN on this new technology

Sponsored

Elon Musk's rival space-faring company, NASA, just partnered up with this little known company… Why? Because this tiny company holds the key to a $7 Trillion Dollar revolution. Most mainstream investors have no idea this $7 Trillion Revolution is taking place… But while everyone else is distracted by AI, this new phenomenon is quietly taking the tech world by storm… Companies like Google, Intel, and Microsoft are SCRAMBLING to get ahead of it… Even Bill Gates is ALL-IN on this new innovation… “…It's as revolutionary as the personal computer, the Internet, and the mobile phone.” It's no wonder why NASA decided to partner up with the leading company in this silent revolution… >>Click here to discover the innovation that has NASA and Bill Gates so excited.

Get The Name Of This Coin ASAP

Enter your email address below to reveal the name of this coin that is set to soar.



By submitting your email address, you give Smart Investor's Daily permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

Get The Name Of This Coin ASAP

Enter your email address below to reveal the name of this coin that is set to soar.



By submitting your email address, you give Smart Investor's Daily permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

Get The Name Of This Coin ASAP

Enter your email address below to reveal the name of this coin that is set to soar.



By submitting your email address, you give Smart Investor's Daily permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

Warren Buffet's #1 Favorite Investment

Learn how to invest in the specific type of private investment that netted Warren Buffett a combined $27 Billion in profits.

Enter Your Email Below To Get The Details



By submitting your email address, you give Smart Investor's Daily permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

How To Invest In Elon's New "Project X"

Take a moment right now and unlock this shocking video.

I just saw this from my friend, veteran trader Tim Bohen.

He says this video details a mega trading opportunity right now, that could blow up in the weeks to come.

In fact, he says, just one tweet from Elon Musk could blow this story wide open on or before April 25. 

Enter Your Email Below To Unlock The Video



By submitting your email address, you give Smart Investor's Daily permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

How To Invest In The Tiny Company Behind the "Forever Battery"

It’s called the “Forever Battery” and this groundbreaking technology could be the biggest story of 2022. Get the details on how to invest in this exciting startup from early-stage investing expert Charles Mizrahi.

Enter Your Email Below To Watch The Free Presentation Revealing the Name & Ticker



By submitting your email address, you give Smart Investor's Daily permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

The #1 Stock of A Generation

Adoption of “Imperium” is set to happen faster than the internet in the 90’s. One $2 stock is positioned to cash in on the explosive growth.

Enter Your Email Below To Get The Name & Ticker of The $2 Stock At The Center Of The “Imperium” Breakthrough



By submitting your email address, you give Smart Investor's Daily permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

The #1 Blockchain Investment For 2022

Blockchain technology burst into the mainstream in 2021. Institutional investors have been pouring money into a variety of highly promising opportunities, but one investment stand out as the single biggest blockchain opportunity.

Enter Your Email Below To Watch Jeff Brown’s Free Presentation Revealing the #1 Blockchain Investment of 2022



By submitting your email address, you give Smart Investor's Daily permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works